Search Results - "Alisi, A"

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis by Alisi, A., Bedogni, G., Baviera, G., Giorgio, V., Porro, E., Paris, C., Giammaria, P., Reali, L., Anania, F., Nobili, V.

“…Summary Background Gut microbiota modifiers may have beneficial effects of non‐alcoholic fatty liver disease (NAFLD) but randomised controlled trials (RCT) are…”
Get full text

Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat by Della Corte, C., Mosca, A., Majo, F., Lucidi, V., Panera, N., Giglioni, E., Monti, L., Stronati, L., Alisi, A., Nobili, V.

“…Summary Objective The aim of this study was to evaluate the metabolic effects of fatty pancreas (nonalcoholic fatty pancreas disease – NAFPD) in a group of…”
Get full text

Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children by Nobili, V, Alisi, A, Della Corte, C, Risé, P, Galli, C, Agostoni, C, Bedogni, G

“…Abstract Background and aim Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in children. We tested whether dietary supplementation…”
Get full text

Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children by Zusi, C., Morandi, A., Maguolo, A., Corradi, M., Costantini, S., Mosca, A., Crudele, A., Mantovani, A., Alisi, A., Miraglia del Giudice, E., Targher, G., Maffeis, C.

“…The association between non-alcoholic fatty liver (NAFL) and the variant rs641738 within the membrane bound O-acyltransferase domain-containing 7 (MBOAT7) gene…”
Get full text

Editorial: probiotics in NASH – more studies are needed; authors' reply by Alisi, A., Nobili, V.

Get full text

Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity? by Nobili, V., Alisi, A., Grimaldi, C., Liccardo, D., Francalanci, P., Monti, L., Castellano, A., de Ville de Goyet, J.

“…Summary Background Hepatocellular carcinoma (HCC) may develop from non‐alcoholic fatty liver disease (NAFLD) either in the presence or in the absence of…”
Get full text

The correlation of the number of hepatic galectin-3+ cells with NAFLD-related liver damage in children by Panera, N, Oliveira, F, De Stefanis, C, Crudele, A, Nobili, V, Alisi, A

Get full text

A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease by Nobili, V, Bedogni, G, Alisi, A, Pietrobattista, A, Alterio, A, Tiribelli, C, Agostoni, C

“…Objective:Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disease characterised by accumulation of large-droplet fat in hepatocytes with…”
Get full text

Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes by Gnocchi, D, Massimi, M, Alisi, A, Incerpi, S, Bruscalupi, G

“…Non-alcoholic fatty liver disease (NAFLD) is nowadays considered as one of the most serious pathological conditions affecting the liver. NAFLD is supposed to…”
Get more information

Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease by Pampanini, V., Inzaghi, E., Germani, D., Alterio, A., Puglianiello, A., Alisi, A., Nobili, V., Cianfarani, S.

“…Fetuin-A has been proposed as a marker of liver damage in adults with obesity-related NAFLD. The aim of this study was to test serum fetuin-A concentrations in…”
Get full text

Nocturnal Increase of Circulating Fibroblast Growth Factor 21 is Correlated with Severity of Non-Alcoholic Fatty Liver Disease in Children by Crudele, A, Mosca, A, Corte, C.D, Panera, N, Nobili, V, Alisi, A

Get full text

Validity of Non-Invasive Fibrosis Scores in a Large Cohort of Paediatric NAFLD by Mann, J.P, Armstrong, M.J, Mosca, A, Alisi, A, Raponi, M, Baumann, U, Nobili, V

Get full text

Enhancing the Efficacy of Hepatocellular Carcinoma Chemotherapeutics with Natural Anticancer Agents by Alisi, A, Balsano, C

“…Hepatocellular carcinoma (HCC) is a common cancer worldwide. A majority of HCC patients present with an unresectable or metastatic HCC and systemic therapy…”
Get full text

P0310 : FAK/EZH2 functional interaction is crucial for HCC development and progression both in vivo and in vitro by Gnani, D, Ceccarelli, S, Artuso, S, De Stefanis, C, Panera, N, Crudele, A, Nobili, V, Leonetti, C, Alisi, A

Get full text

P1070 : The marker of macrophage activation soluble CD163 is associated with liver histology in children with non-alcoholic fatty liver disease by Kazankov, K, Møller, H.J, Alisi, A, De Vito, R, Vilstrup, H, Nobili, V, Grønbæk, H

Get full text

Sensitive non-invasive circulating markers in paediatric non-alcoholic fatty liver disease by Alisi, A., Nobili, V.

Get full text

Analysis of the association of pediatric NAFLD with two SNPs of genes encoding for fibroblast growth factors 19 and 21 receptor system by Crudele, Ceccarelli, S, Panera, N, Gnani, D, De Stefanis, C, Alisi, A, Nobili, V

Get full text

FAK depletion/inhibition reduces the expression of liver cancer stem cells markers by Romito, I, Gnani, D, Artuso, S, De Stefanis, C, Panera, N, Crudele, A, Balsano, C, Carcarino, E, Nobili, V, Rota, R, Leonetti, C, Alisi, A

Get full text

Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD by Nobili, V, Reale, A, Alisi, A, Morino, G, Trenta, I, Pisani, M, Marcellini, M, Raucci, U

“…Abstract Background Non-alcoholic fatty liver disease, ranging from hepatic steatosis to necro-inflammation with or without fibrosis (non-alcoholic…”
Get full text

1281 LC3 DEREGULATION AND AUTOPHAGY SUPPRESSION DURING HEPATOSTEATOSIS by Panera, N, Ceccarelli, S, De Stefanis, C, Alisi, A, Nobili, V

Get full text